| Bristol Myers Squibb Signs US$15.2 B Licensing Pact with Hengrui Pharma for Medicines Across Oncology, Haematology, and Immunology |
Abstract
pdf
html
|
|
Sanya Sekhri |
|
| Madrigal Pharmaceuticals Inks US$1 B pact with Arrowhead Pharmaceuticals to Advance RNAi Therapy for MASH |
Abstract
pdf
html
|
|
Nikita Negi |
|
| Sun Pharma to Acquire Organon for US$11.75 B |
Abstract
pdf
html
|
|
Ayush Saxena |
|
| Lilly Acquires Kelonia Therapeutics for US$7 B to Expand In Vivo CAR T Capabilities |
Abstract
pdf
html
|
|
Nikita Negi |
|
| Chiesi Expands Global Rare Disease Portfolio with US$1.9 B Acquisition of KalVista Pharmaceuticals |
Abstract
pdf
html
|
|
Sanya Sekhri |
|
